stoxline Quote Chart Rank Option Currency Glossary
Electromed, Inc. (ELMD)
14.37  -0.13 (-0.9%)    06-18 12:23
Open: 14.39
High: 14.525
Volume: 7,197
Pre. Close: 14.52
Low: 14.37
Market Cap: 124(M)
Technical analysis
2024-06-18 12:19:16 PM
Short term     
Mid term     
Targets 6-month :  18.83 1-year :  20.36
Resists First :  16.12 Second :  17.44
Pivot price 14.74
Supports First :  14 Second :  11.64
MAs MA(5) :  14.65 MA(20) :  15.09
MA(100) :  15.08 MA(250) :  12.32
MACD MACD :  -0.5 Signal :  -0.5
%K %D K(14,3) :  22.9 D(3) :  23.2
RSI RSI(14): 40.2
52-week High :  18.6 Low :  8.8
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ ELMD ] has closed above bottom band by 18.1%. Bollinger Bands are 76.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 14.71 - 14.8 14.8 - 14.86
Low: 14.15 - 14.27 14.27 - 14.35
Close: 14.35 - 14.52 14.52 - 14.64
Company Description

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Headline News

Wed, 05 Jun 2024
Electromed (NYSE:ELMD) Trading Up 2.5% - MarketBeat

Thu, 30 May 2024
(ELMD) Proactive Strategies - Stock Traders Daily

Wed, 08 May 2024
Electromed, Inc. (AMEX:ELMD) Q3 2024 Earnings Call Transcript - Yahoo Finance

Tue, 07 May 2024
Electromed Inc (ELMD) Announces Record Q3 Revenue, Surpassing An -

Wed, 15 Feb 2023
Electromed CEO Kathleen Skarvan is retiring - Minneapolis / St. Paul Business Journal

Tue, 03 Jan 2023
The 7 Best Stocks Under $20 to Buy Now - InvestorPlace

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical - Devices
Shares Out 9 (M)
Shares Float 6 (M)
Held by Insiders 25 (%)
Held by Institutions 34 (%)
Shares Short 35 (K)
Shares Short P.Month 38 (K)
Stock Financials
EPS 0.37
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 4.44
Profit Margin 6.5 %
Operating Margin 1.1 %
Return on Assets (ttm) 6 %
Return on Equity (ttm) 8.9 %
Qtrly Rev. Growth 15.6 %
Gross Profit (p.s.) 4.25
Sales Per Share 5.79
EBITDA (p.s.) 0.55
Qtrly Earnings Growth 89.3 %
Operating Cash Flow 3 (M)
Levered Free Cash Flow 1 (M)
Stock Valuations
PE Ratio 39.16
PEG Ratio 1.8
Price to Book value 3.25
Price to Sales 2.49
Price to Cash Flow 44.88
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android